Raltegravir can be used safely in HIV-1-infected patients treated with warfarin

Int J STD AIDS. 2012 Dec;23(12):903-4. doi: 10.1258/ijsa.2012.012085.

Abstract

Drug co-administration often affects the patient response to warfarin through various mechanisms. We describe here five HIV-1-infected patients on treatment with warfarin in whom the use of raltegravir was associated with a favourable outcome.

Publication types

  • Case Reports

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Anticoagulants / therapeutic use
  • Drug Interactions
  • HIV Infections / blood*
  • HIV Infections / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Pyrrolidinones / therapeutic use*
  • Raltegravir Potassium
  • Treatment Outcome
  • Warfarin / therapeutic use*

Substances

  • Anti-HIV Agents
  • Anticoagulants
  • Pyrrolidinones
  • Raltegravir Potassium
  • Warfarin